Article info

PDF
Short report
Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

Authors

  1. Correspondence to Dr Satoshi Kuwabara, Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp
View Full Text

Citation

Sekiguchi Y, Misawa S, Shibuya K, et al
Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

Publication history

  • Received December 31, 2012
  • Revised February 3, 2013
  • Accepted February 6, 2013
  • First published March 5, 2013.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.